Innovating Works

ASTRACIME

Inactiva
NANO-GROWTH: An innovative non invasive and de risked system to enable the transdermal delivery of fragile thera... ASTRACIME tramitó un H2020: H2020-SMEInst-2016-2017 Chronic pain affects +1.5 billion people worldwide, which means that pain affects more people than diabetes, heart disease and cancer combin...
2017-01-23 - 2017-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.